AC Immune SA(NASDAQ:ACIU) 
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, ...
Website: http://www.acimmune.com
Founded: 2003
Full Time Employees: 115
CEO / Founder: Andrea Pfeifer
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.75
H 1.79
L 1.64
C 1.66
V 249,120
10EMA 1.66
20EMA 1.66
60EMA 1.66
120EMA 1.66
250EMA 1.66